NEW YORK, July 24, 2026 /PRNewswire/ — As International Self-Care Day draws attention to the importance…
Category: News
FDA Approves TYLENOL® with Naproxen, the First and Only Over-the-Counter Fixed-Dose Combination of Acetaminophen (650 mg) and Naproxen Sodium (220 mg)
TYLENOL® with Naproxen is a clinically proven, opioid-free, fixed-dose combination that begins working in under 30…
Armor Health Selected to Provide Healthcare Services for the Lucas County Corrections Center in Toledo, Ohio
MIAMI, July 24, 2026 /PRNewswire/ — Armor Health (ArmorHealthcare.com), a leading national provider of comprehensive correctional…
American Regent, Inc. Issues Voluntary Nationwide Recall of One Lot of Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL Due to the Presence of Visible Particulate Matter
SHIRLEY, N.Y., July 24, 2026 /PRNewswire/ — American Regent, Inc. is conducting a nationwide voluntary recall…
Vector Science & Therapeutics Reports First Quarterly Financial Results as a Public Company; Announces Inaugural Investor Q&A on July 28
Peptide manufacturing vertical on track to begin generating revenue in August 2026; VectorMist™ 510(k) submission advancing…
Creating Healthier Communities Convenes National Leaders to Launch Bold Goal: Cut America’s Life Expectancy Gap in Half Within a Decade
Inaugural CHC National Forum rallies leaders aroundBuilt to Thrive research revealing the $1.4 trillion cost of…
Washington Family Sues Nara Organics and Target After Their Infant Was Hospitalized with Botulism from Recalled Organic Formula
The Botulism attorneys at Marler Clark filed a lawsuit, naming Target as the retailer of the…
Why Consumers Are Exploring PureHealth Research Optimal Health Supplements for Everyday Wellness
MANASSAS, Va., July 25, 2026 /PRNewswire/ — Proactive wellnesshas become one of the most talked-about themes…
Video: USF Athletics and Tampa General Hospital Unveil New Football Uniforms Featuring Tampa General Hospital Patch
The reveal marks the debut of a landmark partnership establishing Tampa General as the first jersey…
Nona Biosciences Enters Research Collaboration with the Medical University of Vienna to Advance Fully Human Antibody Development for Infectious Diseases
Partnership grants Ignaz Semmelweis Institute access to Nona’s H2L2 Harbour Mice® transgenic mouse technology platform for…